Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
Status:
Not yet recruiting
Trial end date:
2028-10-01
Target enrollment:
Participant gender:
Summary
The information learned in these studies will help to inform doctors as to how to
appropriately adjust doses of cannabidiol and tacrolimus in order to improve health outcomes
and long-term treatment success for transplant recipients.